DRKS00003193
Recruiting
Not Applicable
Evaluation of Ultrahigh-Field-MRI at 7 Tesla for Imaging of ischemic lesions, carotid plaque morphology and brain perfusion - 7 UP - 7-UP
Charité Campus Charité Mitte0 sites100 target enrollmentAugust 12, 2011
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- I63.9
- Sponsor
- Charité Campus Charité Mitte
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •General inclusion criteria:
- •\-Stable patient condition not requiring in\-hospital treatment
- •\-Age: 18 – 80 years
- •\-Preserved ability to give informed consent
- •\-Informed consent
- •\-Legal competence
- •Specific inclusion criteria
- •\-sub\-project 1:
- •oCortical/sub\-cortical infarcts
- •\-sub\-project 2:
Exclusion Criteria
- •\-cardiac pacemaker or any other magnetic implant
- •\-every kind of metallic or electro\-(magnetic) implant
- •\-pregnancy and breastfeeding period
- •\-claustrophobia
- •\-chronic or episodic vertigo
- •\-diseases of the retina (e.g. retinal detachment or macula degeneration)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Validation of ultrahigh field (7 Tesla) MRI with whole mount pathology in rectal cancerrectal cancer10027655NL-OMON48569niversitair Medisch Centrum Utrecht10
Completed
Not Applicable
Feasibility of ultra high field 7.0 Tesla MRI for the detection of breast cancerbreast cancerbreast neoplasm10006291NL-OMON34075niversitair Medisch Centrum Utrecht20
Completed
Not Applicable
Feasibility of ultra high field 7.0 Tesla MRIfor the detection of breast cancer.Breast tumorBreast neoplasmNL-OMON20303niversity Medical Center Utrecht (UMCU)Visiting address-----------------------Heidelberglaan 1003584 CX UtrechtThe NetherlandsPostal address---------------------Room E01.132PO Box 855003508 GA UtrechtThe NetherlandsPhone: +31 (0)88 75 555 5520
Terminated
Not Applicable
Ultra High Field MRI and MRS Techniques in Diagnosing Breast CancerBreast CancerNCT01938651Vanderbilt-Ingram Cancer Center3
Completed
Not Applicable
Feasibility of ultra high field 7.0 Tesla MR Spectroscopy for monitoring neo-adjuvant therapy efficacy.breast cancerbreast neoplasm10006291NL-OMON38209niversitair Medisch Centrum Utrecht15